Your browser doesn't support javascript.
loading
Redefining Cardiac Involvement and Targets of Treatment in Systemic Immunoglobulin AL Amyloidosis.
Porcari, Aldostefano; Masi, Ambra; Martinez-Naharro, Ana; Razvi, Yousuf; Patel, Rishi; Ioannou, Adam; Rauf, Muhammad U; Sinigiani, Giulio; Wisniowski, Brendan; Filisetti, Stefano; Currie-Cathey, Jasmine; O'Beara, Sophie; Kotecha, Tushar; Knight, Dan; Moon, James C; Sinagra, Gianfranco; Virsinskaite, Ruta; Gilbertson, Janet; Venneri, Lucia; Petrie, Aviva; Lachmann, Helen; Whelan, Carol; Kellman, Peter; Ravichandran, Sriram; Cohen, Oliver; Mahmood, Shameem; Manisty, Charlotte; Hawkins, Philip N; Gillmore, Julian D; Wechalekar, Ashutosh D; Fontana, Marianna.
Afiliação
  • Porcari A; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom.
  • Masi A; Centre for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), University of Trieste, Trieste, Italy.
  • Martinez-Naharro A; European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart (ERN GUARD-HEART), Trieste, Italy.
  • Razvi Y; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom.
  • Patel R; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom.
  • Ioannou A; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom.
  • Rauf MU; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom.
  • Sinigiani G; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom.
  • Wisniowski B; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom.
  • Filisetti S; Department of Cardio-Thoraco-Vascular Sciences and Public Health, University of Padua, Padua, Italy.
  • Currie-Cathey J; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom.
  • O'Beara S; Cardiology University Department, Heart Failure Unit, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy.
  • Kotecha T; Faculty of Medicine, University of Milano, Milan, Italy.
  • Knight D; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom.
  • Moon JC; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom.
  • Sinagra G; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom.
  • Virsinskaite R; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom.
  • Gilbertson J; Institute of Cardiovascular Science, University College London, London, United Kingdom.
  • Venneri L; Barts Heart Centre, West Smithfield, London, United Kingdom.
  • Petrie A; Centre for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), University of Trieste, Trieste, Italy.
  • Lachmann H; European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart (ERN GUARD-HEART), Trieste, Italy.
  • Whelan C; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom.
  • Kellman P; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom.
  • Ravichandran S; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom.
  • Cohen O; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom.
  • Mahmood S; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom.
  • Manisty C; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom.
  • Hawkins PN; National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.
  • Gillmore JD; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom.
  • Wechalekar AD; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom.
  • Fontana M; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom.
JAMA Cardiol ; 2024 Aug 21.
Article em En | MEDLINE | ID: mdl-39167388
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: JAMA Cardiol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: JAMA Cardiol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido